Stay updated on Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial
Sign up to get notified when there's something new on the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page.

Latest updates to the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check21 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check64 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and a new date (2025-04-11), replacing the previous version (v2.14.4) and date (2025-03-10).SummaryDifference2%
- Check71 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 10, 2025.SummaryDifference0.7%
- Check100 days agoChange DetectedThe date has been updated from February 27, 2025, to March 10, 2025.SummaryDifference0.7%
Stay in the know with updates to Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenalidomide vs Observation in High-Risk Smoldering Myeloma Clinical Trial page.